Close Menu

S. aureus

DxNA, a privately owned St. George, Utah-based molecular diagnostics firm, will acquire privately held Flagstaff, Ariz.-based Pathogene for an undisclosed amount under an agreement inked by the companies this week.

NEW YORK (GenomeWeb News) – The US Department of Defense has granted investigators at the University of Washington and their partners $9.6 million to support the development of a paper-based molecular diagnostic testing system that could be used in remote regions and in homes around the world by

A flurry of recently published peer-reviewed papers has demonstrated the growing breadth and diversity of applications for Bio-Rad's QX100 Droplet Digital PCR system.

DxNA has acquired exclusive rights to run PathoGene's multiplexed Staphylococcus MRSA+ assay on DxNA's real-time PCR-based GeneStat platform, the companies said this week.

NEW YORK (GenomeWeb News) – AdvanDx recently announced the appointment of Alpha Laboratories to support the launch of AdvanDx's molecular QuickFISH test.

The Association for Molecular Pathology's annual meeting, held last week in Long Beach, Calif., focused strongly on next-generation sequencing and its implementation in the clinic, especially for diagnosing, monitoring, and tailoring treatments for cancer.

A team led by researchers at the University of Chicago has identified cysteine phosphorylation as playing a key role in regulating virulence and antibiotic resistance in the human pathogen Staphylococcus aureus.

Finnish molecular diagnostics firm Abacus Diagnostica, fresh off winning a pair of key US patents covering its DNA testing technologies, plans to seek regulatory approval in the US next year for tests to detect Staphylococcus aureus and methicillin-resistant S.

Buoyed by increased researcher interest and new vendor offerings, imaging mass spectrometry is approaching a "tipping point," Vanderbilt researcher Richard Caprioli told ProteoMonitor this week.

This story has been updated from a previous version to include information about BD's ongoing assay-development partnership with Diagenode.

Pages

The New York Times Magazine examines gender discrimination at the Salk Institute.

Science reports that MD Anderson Cancer Center has dismissed three researchers over foreign tie concerns.

A second death in gene therapy trial for type 1 spinal muscular atrophy is under investigation, according to Reuters.

In PLOS this week: antibiotic resistance patterns in Escherichia coli, a dozen genetic loci tied to varicose vein risk, and more.